Evaluation of the response to vaccination with hepatitis B vaccine in pediatric patients diagnosed with celiac disease.

SAGE Open Med · 2014 · PMC4607240 · PMID 26770758

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

marginally significantp = 0.061so close (0.05 < p ≤ 0.1)

In the univariate analysis, time between completion of hepatitis B vaccination and diagnosis and the presence of comorbidities were marginally significant predictors for an antibody response to HBV (OR = 0.87, p = 0.061, and OR = 2.77, p = 0.07, respectively) ( Table 3 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.